The protective effect of the CFHR3-CFHR1 deletion has been previously described in two Spanish C3G cohorts, immunoglobulin A nephropathy (IgAN), and age-related macular degeneration (20, 40–45). Here, CFHR1 is linked to age-related macular degeneration.